Pfizer's stock rose in the intraday levels, amid the dominance of the main upward trend in the medium and short terms, with positive signals from the RSI after reaching overbought levels, scoring a fresh profit of 1.13% in the last session, or 0.49 points, amid positive pressure from the 50-day SMA.
Therefore we expect more gains for the stock, targeting the resistance of 44.45, as long as it settles above 42.77.
Expected trend for today: Bullish